World Journal of Pharmaceutical Sciences
ISSN (Print): 2321-3310; ISSN (Online): 2321-3086
Published by Atom and Cell Publishers © All Rights Reserved
Available online at: http://www.wjpsonline.org/
Review Article
Contingent analysis and evaluation of pharmaceutical product recall procedure of USA
and India
Pasumarthy N. V. Gopal1, *Pichukala Anusha2, T. Lakshmi2, M. V. Nagabhushanam2, D. Nagarjuna Reddy2
1
Department of Pharmaceutical Biotechnology, Hindu College of Pharmacy, Guntur, AP, India-522002
Department of Pharmaceutical Management and Regulatory Affairs, Hindu College of Pharmacy, Guntur, AP,
India-522002
2
Received: 21-10-2014 / Revised: 11-11-2014 / Accepted: 17-11-2014
ABSTRACT
In this developed era with escalating health complications there are number of new drugs breaching the market.
Post market clinical trials revealed that many drugs available in the market cause adverse effects. Regulatory
authorities recall those defective drugs in the market based on the guidelines framed by the regulatory
authorities of respective countries. In USA, guidelines for pharmaceutical product recall are described under 21
CFR Parts 7, 107 and 1270. In India, references for pharmaceutical product recalls, complaint and adverse
reactions are mentioned in Para 27, 28 of Schedule M and conditions of license for defective product recall in
Rule 74(j) and Rule 78(i) and banned drugs under 26A of the Drugs and Cosmetics Act, 1940 and Rules. In this
paper we discussed about recall procedure of pharmaceutical products and comparative study in USA and India.
Key words: Recall, Regulatory Guidelines, Procedure.
INTRODUCTION
DISCUSSION
The pharmaceutical arena is widely spread,
profitable sector and the global market is expected
to grow 5 - 8% annually through 2014. To
manufacture and market the pharmaceutical
products first the manufacturer must follow the
approval guidelines of the respective country‟s
regulatory authority and after getting the approval
the manufacturer is entitled to manufacture and
market the drugs. Few a times the manufacturer or
regulatory authority recall the products that is
disbursed in the market when they receive
complaints from any physician, consumer,
pharmacovigilance person or if the manufacture
observe any defects during the inspection or
auditing of their product manufacturing process or
in the market by the regulatory authorities. “Recall
means a firm‟s removal or correction of a marketed
product that the food and drug administration
considers to be in violation of the laws it
administers and against which the agency would
initiate legal action” according to 21 CFR 7.3(g)2
Recall is a removal or correction of marketed
products for the reasons related to deficiencies in
quality, safety or efficacy, including labeling
considered to be in violation of the laws according
to Drug and Cosmetics Act 1940 & rules.
Recall Classification: Recalls classified into 3
types based on the extent of health risk on exposure
of defective products.
Class I: In Class I recall there is a reasonable
possibility that the use of, or exposure to, a
defective product will cause serious adverse health
consequences or death.
Class II: In Class II recall there is a possibility that
the use of, or exposure to, a defective product may
cause temporary adverse health consequences or
where the probability of serious adverse health
consequences is improbable.
Class III: In Class III recall the use of, or exposure
to, a defective product is not likely to cause any
adverse health consequences.
USA3: In USA FDA- Food and Drug
Administration is the regulatory authority under
Department Of Health and Human Services. FDA
frame regulations for Food, Pharmaceutical Drugs
(Prescription and Over the Counter Drugs, Dietary
supplements, Vaccines, Bio pharmaceuticals,
Blood transfusions, Medical devices, Radiation
emitting devices, Veterinary products, Cosmetics
and tobacco products to protect public health and
also monitor the recall of those products.
*Corresponding Author Address: Anusha.Pichukala, Department of Pharmaceutical Management and Regulatory Affairs, Hindu College
of Pharmacy, Acharya Nagarjuna University, Guntur, India, E-mail: pavkr.243@gmail.com
Anusha et al., World J Pharm Sci 2014; 2(12): 1728-1735
Recommendation to CRU and OEIO/DE through
RES.
Recall Recommendation contain the following
Product Description (INT), Trade Name,
and Product Usage fields
Code Information
Recalling Firm/Manufacturer/Responsible
Firm
Reason for Recall Recommendation
Volume of Product in Commerce
Distribution Pattern
LAWS AND REGULATIONS
The regulations for product recall given in different
parts of 21 CFR
21CFR Part 7, Subparts A and C - Recalls General guidelines
21CFR Part 107, Subpart E - Mandatory recall of
Infant Formula
21 CFR Part 1270 - Human Tissue
PHS Act - 42 U.S.C. 262 - Mandatory recall of
biological products
21 CFR Part 806 - Medical Device Corrections and
Removals
FD&C Act, 518(e) - Mandatory Device Recalls
4. Official Samples: The district will collect
samples to demonstrate the potential hazard.
STEPWISE RECALL PROCEDURE IN USA4
1. Initiation of recall: Initiation of recall may be
voluntary or statutory recall (FDA requested or
FDA mandated).
Voluntary recall: If the firm wants to recall a
product on its own (given in 21 CFR 7.46(a)). It
happens when the firm detects any defect in
product during inspection.
Statutory recall: If regulatory authority identifies
any defect or violation of law during manufacture
of product then they send a contact manufacturer to
initiate recall then it is a FDA requested recall
(given in 21 CFR 7.45). The Associate
Commissioner for Regulatory Affairs (ACRA)
approves all FDA requested recalls. If regulatory
authority sends a letter to initiate recall is called
FDA mandated recall. The firm should notify about
recall to the district authority.
5.
Firm Recall
Communication:
Firm
communicate about recall through fastest mode of
communication such as press releases, telephone
calls, telegrams, telefaxes, mailgrams, and first
class letters. Guidelines given to Recall
communication and it should contain following
It should be brief and to the point
To clearly identify the product(s) it should
include product name, size, brand name,
serial numbers(s), potency, dosage, type,
model, lot number(s), UPC codes, Unique
Device Identifier (UDI) etc.
Should contain a concise statement of the
reason for the recall
It should state known or potential
hazard(s), and instructions for consignees
to follow in handling the recall
2. Recall alert: Within 24 hours after decided to
recall a product the district should inform to CRU
(Central Recall Unit) and OEIO (Office of
Enforcement and Import Operations)/DE (Division
of Enforcement). Then district submit the Recall
Alert through RES (Recall Enterprise System) to
CRU and OEIO/DE
Recall Alert should contain the following
Product(s) Description
Codes
Recalling Firm
Short Reason for Recall
District Awareness Date
Recall Initiation Date, with Type Initial Firm
Notification
Recall Status
Voluntary or FDA Mandated Pick Lists, with
Date
6. Health Hazard Evaluation and Classification
of Recalling Product: CRU initiates health hazard
evaluation for each recall. If the product identical
to defect of previous recall product then they use
precedent HHEs otherwise CRU forward
information to Center Health Hazard Evaluation
Committee. Center Health Hazard Evaluation
Committee use work sheets to record their
evaluation according to 21 CFR7.41 (a). Based on
result of evaluation CRU classifies recall within 2
days.
7. Recall Number5: Generally after classification
recall number given to that recalling product.
Recall number assigned by responsible center for
each recalled product. It consists of a letter which
indicates the responsible center, 3 or 4 digit
sequential number indicating the number of recalls
initiated by that center in that year, a four digit
number indicating that fiscal year. Example: F-1002013 indicates the 100th recall by the Center for
Food Safety and Applied Nutrition (CFSAN) in the
year 2013
3. Recall Recommendation (RR): After
submitting the recall alert within 5working days the
district
submits
a
complete
Recall
1729
Anusha et al., World J Pharm Sci 2014; 2(12): 1728-1735
Letter
F
D
Z
V
B
N
A
Center
-
CFSAN
Center for Drug Evaluation and Research (CDER)
Center for Devices and Radiological Health (CDRH)
Center for Veterinary Medicines (CVM)
Center for Biologics Evaluation and Research (CBER)
Medical Devices (Voluntary Safety Alerts and Notifications)
Audit Numbers issued by the district performing the recall
8. Recall Strategy: Recall strategy based on the
recall classification. If it‟s a voluntary recall then
the CRU will review the recalling firm‟s recall
strategy and give suggestions if required. CRU will
develop recall strategy for FDA requested recalls.
Recall strategy include type of notification, depth
of recall, level of audit checks, need for public
warning. If the regulatory authority approves an
industry Corrective Action Program (CAP) for
radiation emitting electronic product, any device
then regulatory authority inform the firm that its
CAP is classified as a recall.
the recalling firm has fulfilled all recall activity,
recalled product disposition.
INDIA6: In India CDSCO (Central Drug Standard
Control Organization) under Ministry Of Health
and Family Welfare is a national regulatory body
responsible for recalls of drug, medical devices,
biological and vaccines.
LAWS AND REGULATIONS7: Guidelines on
recall given in the Drugs & Cosmetics Act 1940 &
Rules, there are references for drug product recalls,
complaint and adverse reactions in Para 27 & 28 of
Schedule M and also conditions of license for
defective product recall in Rule 74(j) and Rule
78(i). Banned drugs under Section 26A
9. Notification of other Government and
Agencies: OECD/DE is
responsible for
maintaining contact with all other organizations
like CRU, Office of Partnership (OP), Office of
International Programs (OIP), and Media Relations
Staff in the Office of Public Affairs etc. OEIO/DE
informs the OIP of all Class I recall where product
was distributed to foreign countries except Canada.
OEIO/DE informs Canadian food, drug and device
regulatory authorities of every recall in accordance
with established communication agreement.
STEPWISE
INDIA8
RECALL
PROCEDURE
IN
1. Initiation of Recall: Recall initiated if they get
complaints from any customer, physician etc. the
complaint9 should include
Name, dosage form, package form, batch no
Date and the place of occurrence of complaint
Cause of complaint;
Name and address of complaint in detail.
Any defects observed in the product which effect
the safety and quality of product recall should be
initiated without any delay (Section 25(3) and
Section 25(4) of the Drugs & Cosmetics Act 1940
& Rules). Recall initiated may be voluntary recall
or statutory recall.
Voluntary recall: Recall initiated by the
manufacturer
Statutory recall: Recall initiated by Drug Control
Authority
10. Public Warning: All recalls classified by
agency will be included in FDA‟s weekly
enforcement report. Recall press releases are posted
in FDA‟s website „Recalls, Marketing withdrawals,
and Safety Alerts‟.
11. Audit Checks: The district will issue audit
check within 10days after issuance of RR. Audits
are conducted to check the effectiveness of recall
process. Recall effectiveness is recalling firm‟s
responsibility. Sometimes recalling firm fail to
check effectiveness where depth of recall extend to
consumer level because retailers were not likely to
disclose the information of their customers
(patients) where the firm obtain agencies help.
During FDA audit at any instant agency feel that
recalling firm recall process is not effective then
agency notify the firm. After notification firm show
any interest to modify its recall then agency will
take appropriate action such as multiple seizures
and injunction.
2. Assigning Recall Number: After taking
decision to recall, the representative of recalling
firm fill the Recall log and assign Recall Number
to that product along with details (product name,
product number, lot number, intended use, etc.,)
3. Recall Alert: The recalling firm representative
should inform about recall product with seriousness
of product effect on usage to all retailers,
distributors, consumers using the fastest mode of
communication which may include email,
telephone, fax, SMS etc.
12. Recall Termination: Recall will be terminated
by FDA if the monitoring district concludes that
1730
Anusha et al., World J Pharm Sci 2014; 2(12): 1728-1735
4. Notification to Regulatory Authority: If it‟s a
voluntary recall the recalling firm should inform
about recall to regulatory authority where the
product in market. The DCGI member or Drug
inspector of that area block that product to be
recalled. The information about recalling product
placed in Safety Alerts in CDSCO website
(www.Cdsco.in).
8. Recall Termination: After ensuring that the
product recall completed within the stipulated time
regulatory authority terminate the recall.
CONCLUSION
Pharmaceutical industry is one of the important
sector to both USA and Indian economy. In this
project study conducted on product recall
procedure of pharmaceutical industry in USA and
India. Recall of any product is not a good issue to
any pharmaceutical company. Recalling a product
is not an easy task because once the product
entered into the market it is difficult to recover that
product. The retailers were not likely to disclose
the information of their customers (patients). Recall
of any product is greatly affect the economy,
goodwill of the manufacturing company. But if the
company follows better management activities
recalling it can be done smoothly. The number of
recalls increasing year by year which greatly
affects the public health so, need to decrease
number of recall is necessary. The regulatory
authorities and Pharmacovigilance should monitor
the pharmaceutical firms closely to decrease the
number of recall. The regulatory authorities should
also monitor the disposing or waste management
methods of recalled product because if they not
properly dispose those potent drugs it may affect
the environment and human health. Every
pharmaceutical company should conduct mock
recalls to ensure effectiveness of the arrangements
of recall and also they should conduct internal
inspections, audits to find any mistakes/
mishappenings during manufacturing process. They
should maintain records of every batch
5. Recall Classification of the Product: The state
regulatory authority evaluates the degree of hazard
involved with that product. Based on that
evaluation they classify the product according to
classification given by CDSCO in Drugs &
Cosmetics Act 1940 & Rules.
6. Recovery of Stock: The distributors after
receiving the recall alert they should inform to both
their direct accounts and sub accounts. Immediately
they should block the further distribution of that
product to be recalled. The direct accounts and sub
accounts return the stock available with them and
also stock recovered from the customers to
recalling firm storage head along with Return
Feedback.
7. Follow-Up Action of Recalled Goods: Follow
up action involves the activities to conduct audits
to check the effectiveness of recall and also to
investigate the reason for recall and also to rectify
that mistake to prevent a recurrence of the defect.
The returned goods of recalled products placed in
Quarantine section and conduct inspection to know
the root cause of the product defect. Based on
reason for recall appropriate disposition method
was employed by the licensee.
REFERENCES
1.
2.
3.
4.
5.
6.
7.
8.
9.
Sunil D. Shewale et al Pharmaceutical Product Recall: Lesson Learned, International Pharmaceutical Industry Spring 2014
Volume 6 Issue 1.
CFR – Code of Federal Regulations Title 21, Food and Drug Administration
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?CFRPart=7&showFR=1 (Accessed August 27, 2014)
Food and Drug Administration, Organization
http://www.fda.gov/AboutFDA/CentersOffices/default.htm (Accessed July 09, 2014)
Chapter 7 Regulatory Procedures Manual by Food and Drug Administration in October 2013
Chapter 7 investigations operational manual 2014 by Food and Drug Administration
Central Drug Standard Control Organization
http://www.cdsco.nic.in/forms/contentpage1.aspx?lid=1424 (Accessed July 09, 2014)
The Drugs & Cosmetics Act 1940 & Rules 1945 by Central Drug Standard Control Organization
Guidelines on Recall and Rapid Alert System for Drugs; including biologicals & vaccines by CDSCO (draft version). Published
on 22nd Oct.2012.
Bhupender Kumar Nimbiwal et al., Journal of Drug Discovery and Therapeutics 1 (2) 2013, 15-20. (Accessed October, 2014)
1731
Anusha et al., World J Pharm Sci 2014; 2(12): 1728-1735
Comparative Study of Recall Procedure in INDIA, USA
Feature under
USA
consideration
Recall definition
A Recall is a firm's removal or correction
of a marketed product that FDA considers
to be in violation of the laws it
administers, and against which the
Agency would initiate legal action
Regulatory
authorities
responsible for recall
FDA-Food and Drug Administration
regulates the recalls of drug, food,
biologics, tobacco products, animal
products.
Recall classification
Basis of classification
3 classes
Based on relative degree of health hazard
Types of recall
Voluntary recall, Statutory recall
Recall timeline
Timeline given by CRU based on product
to be recalled.
Rules and guidelines to
recalls
The regulations for product recall given in
different parts of 21 CFR
21CFR Part 7, Subparts A and C - Recalls
General
guidelines
21CFR Part 107, Subpart E - Mandatory
recall
of
Infant
Formula
21 CFR Part 1270 - Human Tissue
PHS Act - 42 U.S.C. 262 - Mandatory
recall
of
biological
products
21 CFR Part 806 - Medical Device
Corrections
and
Removals
FD&C Act, 518(e) - Mandatory Device
Recalls
1732
INDIA
Removal or correction of marketed
products for the reasons relating to
deficiencies in quality, safety or
efficacy,
including
labeling
considered to be in violation of the
laws.
CDSCO-Central Drugs Standard
Coftrol Organization regulates recalls
of drugs, medical devices, biologics,
and vaccines.
FSSAI-Food
Safety
Standards
Authority of India regulates the
recalls of food products.
3 classes
Based on relative degree of health
hazard
Voluntary
recall,
Statutory
recall(FDA
requested/
FDA
mandated)
• Class I - for a time line of within
24 hours up to a maximum of 72
hours.
• Class II - up to a maximum of
10 days
• Class III - up to a maximum of
30 days is allowed.
Given in Para 27, 28 of Schedule M
and conditions of license for defective
product recall in Rule 74(j) and Rule
78(i) and banned drugs under 26A of
the Drugs and Cosmetics Act, 1940
and Rules
Anusha et al., World J Pharm Sci 2014; 2(12): 1728-1735
Flow Chart of Recall Procedure of USA
Recall Initiation (Firm initiated/
FDA requested/ FDA mandated)
Patient, Pharmacovigilance,
physician complaints or
identification of defect during
inspections
Recall Alert and notifying to FDA
(The district, CRU, OEIO/DE)
Health Hazard Evaluation and
Recall classification by CRU
Development of Recall Strategy
OEIO/DE notifies to OIP in case of
product exported to other countries
Public Warning
Conduct Audits to check recall
effectiveness
Recall process effective and
satisfactory
Completion of recall activity and
disposition of product
Recall termination
by FDA
Fig 1: Flow Chart of Recall Procedure in USA
1733
If Recall process
is ineffective
Agency notify to
recalling firm
If firm not responded
to agency
Multiple injunction
and seizure
Anusha et al., World J Pharm Sci 2014; 2(12): 1728-1735
Fig 2: Class I Pharmaceutical Recalls in 2013 by FDA
Fig 3: Total Number of Product Recalls by FDA
1734
Anusha et al., World J Pharm Sci 2014; 2(12): 1728-1735
Flowchart of Recall Procedure in India
Recall
Voluntary recall
Statutory recall
Recall initiated by licensee
Recall requested/ mandated by
regulatory authority/ licensing
authority
Identification of potential defect/
non- compliance issue
Request / notification received
by licensee
QA to take decision on recall as per
the sop of the manufacturing firm
Recall Information to
Distributors/ Marketing
Company/ Wholesaler/ Retailer/
Consumer
Inform to state licensing authority
where product is marketed
Recall log-in by QA/
representative of licensee
Communication to Distributors/
Marketing Company
Distributors/ Marketing Company
calls back the distributed quantity
of product/ batch
Investigation of product/ Batch
Root cause identification &
Documentation
Reconciliation &
Disposition of recalled batch
Fig 4: Flowchart of Recall Procedure in India
1735
Termination
of recall